XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 12.44%17.3B | 28.72%6.14B | 18.93%5.18B | -3.88%3.3B | -5.23%2.68B | 6.19%15.38B | -0.25%4.77B | 11.24%4.35B | 3.75%3.43B | 13.84%2.83B |
Operating revenue | 12.44%17.3B | 28.72%6.14B | 18.93%5.18B | -3.88%3.3B | -5.23%2.68B | 6.19%15.38B | -0.25%4.77B | 11.24%4.35B | 3.75%3.43B | 13.84%2.83B |
Cost of revenue | 8.08%15.24B | 18.36%5.03B | 15.77%4.63B | -2.12%3.14B | -7.72%2.44B | -1.87%14.1B | -14.10%4.25B | 6.66%4B | 0.00%3.21B | 7.23%2.64B |
Gross profit | 60.33%2.06B | 112.81%1.11B | 54.99%544M | -29.41%156M | 29.79%244M | 987.29%1.28B | 422.84%523M | 118.01%351M | 127.84%221M | 754.55%188M |
Operating expense | 5.69%1.32B | 4.11%355M | 5.08%310M | 11.07%341M | 2.63%312M | -1.81%1.25B | -3.13%341M | 2.43%295M | 10.04%307M | -13.39%304M |
Selling and administrative expenses | 7.08%938M | 2.90%248M | 6.57%211M | 12.00%252M | 7.08%227M | 7.75%876M | 13.68%241M | -2.46%198M | 14.80%225M | 4.95%212M |
-Selling and marketing expense | 18.36%535M | 18.80%139M | 20.51%141M | 14.41%127M | 19.63%128M | -2.16%452M | -4.88%117M | 0.00%117M | 3.74%111M | -6.96%107M |
-General and administrative expense | -4.95%403M | -12.10%109M | -13.58%70M | 9.65%125M | -5.71%99M | 20.80%424M | 39.33%124M | -5.81%81M | 28.09%114M | 20.69%105M |
Research and development costs | 2.43%380M | 7.00%107M | 2.06%99M | 8.54%89M | -7.61%85M | -18.82%371M | -28.57%100M | 14.12%97M | -1.20%82M | -38.26%92M |
Operating profit | 1,952.78%739M | 316.48%758M | 317.86%234M | -115.12%-185M | 41.38%-68M | 103.13%36M | 135.41%182M | 144.09%56M | 52.75%-86M | 64.74%-116M |
Net non-operating interest income expense | -6.06%-70M | -6.90%54M | -12.50%-36M | 8.62%-53M | -2.94%-35M | -57.14%-66M | 152.17%58M | 50.77%-32M | -866.67%-58M | -666.67%-34M |
Non-operating interest income | -23.41%157M | ---- | ---- | ---- | ---- | 454.05%205M | ---- | ---- | ---- | ---- |
Non-operating interest expense | -17.45%194M | ---- | ---- | ---- | ---- | 273.02%235M | ---- | ---- | ---- | ---- |
Total other finance cost | -8.33%33M | ---- | ---- | ---- | ---- | 125.00%36M | ---- | ---- | ---- | ---- |
Other net income (expense) | ||||||||||
Special income (charges) | -74.52%53M | 64.71%56M | -300.00%-4M | --0 | -99.42%1M | 146.85%208M | -53.42%34M | -107.69%-1M | -94.29%2M | 130.62%173M |
-Less:Impairment of capital assets | 116.67%2M | 125.00%2M | --0 | --0 | --0 | -117.39%-12M | ---8M | ---2M | 93.94%-2M | --0 |
-Less:Other special charges | 62.91%-56M | -436.36%-59M | --4M | ---- | 99.29%-1M | -231.30%-151M | 97.26%-11M | ---- | ---- | -181.87%-140M |
-Write off | 102.22%1M | 106.67%1M | --0 | --0 | --0 | -117.31%-45M | ---15M | --3M | --0 | -112.18%-33M |
Income before tax | 591.18%705M | 394.80%856M | 557.14%184M | -76.92%-230M | -438.71%-105M | 106.01%102M | 134.81%173M | 116.37%28M | 6.47%-130M | 103.49%31M |
Income tax | 779.17%211M | 975.00%258M | 57M | -393.33%-74M | -300.00%-30M | 119.35%24M | -45.45%24M | 0 | 25.00%-15M | 112.10%15M |
Net income | 533.33%494M | 301.34%598M | 353.57%127M | -35.65%-156M | -568.75%-75M | 104.96%78M | 127.54%149M | 119.05%28M | 3.36%-115M | 102.09%16M |
Net income continuous Operations | 533.33%494M | 301.34%598M | 353.57%127M | -35.65%-156M | -568.75%-75M | 104.96%78M | 127.54%149M | 119.05%28M | 3.36%-115M | 102.09%16M |
Minority interest income | -600.00%-5M | 0 | 0 | 2M | -800.00%-7M | 1M | 1M | -1M | 0 | 1M |
Net income attributable to the parent company | 548.05%499M | 304.05%598M | 337.93%127M | -37.39%-158M | -553.33%-68M | 104.90%77M | 127.36%148M | 119.73%29M | 3.36%-115M | 101.96%15M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 548.05%499M | 304.05%598M | 337.93%127M | -37.39%-158M | -553.33%-68M | 104.90%77M | 127.36%148M | 119.73%29M | 3.36%-115M | 101.96%15M |
Basic earnings per share | 525.00%0.5 | 300.00%0.6 | 333.33%0.13 | -33.33%-0.16 | -800.00%-0.07 | 105.13%0.08 | 128.30%0.15 | 120.00%0.03 | 0.00%-0.12 | 101.32%0.01 |
Diluted earnings per share | 512.50%0.49 | 293.33%0.59 | 333.33%0.13 | -33.33%-0.16 | -800.00%-0.07 | 105.13%0.08 | 128.30%0.15 | 120.00%0.03 | 0.00%-0.12 | 101.32%0.01 |
Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Currency Unit | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR |